ClinicalTrials.gg

Drug

Trebananib clinical trials

Also written AMG 386.

studies test it
29
open now
1
in phase 3
2
first study started
2005

Keep track of what changes. Save the trebananib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

28 studies that test it; most in 2012 (8)

Studies that test trebananib, by start year
YearStudies
20051
20074
20081
20095
20104
20113
20128
20141
20181

By phase

A phase 1/2 study counts in both.

Phase 1
13
Phase 2
15
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 18 · Other 11

Amgen (17) · National Cancer Institute (NCI) (5) · Dana-Farber Cancer Institute (1) · Roswell Park Cancer Institute (1) · Gynecologic Oncology Group (1) · Takeda (1) · QuantumLeap Healthcare Collaborative (1) · Austin Health (1)

Often tested with

Tested in the same studies.

Paclitaxel (4) · Bevacizumab (3) · Pembrolizumab (2) · Sunitinib (2) · Sorafenib (2) · Cytarabine (1) · Motesanib diphosphate (1) · Carboplatin (1)

Studies

Open first, then newest update. How each study uses trebananib is read from its arms, and is right about nine times in ten.

Testing it · 29

See all 29 studies that test trebananib →

Given in every arm · 2 — trebananib is usual care beside what is tested

Codes

What other systems call trebananib · ClinicalTrials.gg INT005678

  • MeSH (NLM) C551398trebananibConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) X8Y5U6NC7ETREBANANIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q104268400trebananibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C91711TrebananibOne source FDA
  • DrugBank DB12056One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.